Palmitoleic Acid ethyl ester

Confirm delete?

Zoom

Cat No: 10008204

Biochemicals - Lipids

Palmitoleic acid (9-hexadecenoic acid) is an unsaturated fatty acid that is found in highest concentration in the liver. It is a common component of the glycerides of human adipose tissues. Two other sources of palmitoleic acid are macadamia oil and se...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

9Z-hexadecenoic acid, ethyl ester

Correlated keywords:

unsaturated fatty acids esters liver glycerides adipose tissues macadamia oils sea buckthorn lipophilic cytosolic calcium Ca2+ pancreas pancreatic acinar cells ethanol death biomarker fetal fetus alcohol

Product Overview:
Palmitoleic acid (9-hexadecenoic acid) is an unsaturated fatty acid that is found in highest concentration in the liver. It is a common component of the glycerides of human adipose tissues. Two other sources of palmitoleic acid are macadamia oil and sea buckthorn oil which contain about 20% and 40% of total fatty acid composition, respectively.{14132,14133} Palmitoleic acid ethyl ester (ethyl palmitoleate) is a more lipophilic form of the free acid. It is one of the fatty acid ethyl esters that increase cytosolic Ca2+ concentration leading to pancreatic acinar cell injury due to excessive consumption of ethanol. Ethyl palmitoleate (10-100 µM) in addition to 850 mM ethanol resulted in sustained, concentration-dependent increases in Ca2+ that caused cell death.{14121} This fatty acid ethyl ester is also a potential biomarker for fetal exposure to alcohol.{14123}

Size	10 mg
Shipping	dry ice
CAS Number	56219-10-4
Molecular Formula	C₁₈H₃₄O₂
SMILES	CCCCCC/C=C\CCCCCCCC(OCC)=O
Molecular Weight	282,5
Formulation	A solution in ethanol
Purity	≥95%
Custom Code	2916.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.